The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 772K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

56 articles for D Kim


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
15
Identification and characterization of potent, selective and metabolically stable IKKß inhibitor.EBI
The Catholic University of Korea
7
Discovery of 2-aryloxy-4-amino-quinazoline derivatives as novel protease-activated receptor 2 (PAR2) antagonists.EBI
Yonsei University
24
Discovery and optimization of adamantane carboxylic acid derivatives as potent diacylglycerol acyltransferase 1 inhibitors for the potential treatment of obesity and diabetes.EBI
Korea Research Institute of Chemical Technology
19
Discovery of novel pyrimidine and malonamide derivatives as TGR5 agonists.EBI
Chung-Ang University
24
Discovery of potent and selective dipeptidyl peptidase IV inhibitors derived from beta-aminoamides bearing subsituted triazolopiperazines.EBI
Merck Research Laboratories
7
Virtual screening identification of novel severe acute respiratory syndrome 3C-like protease inhibitors and in vitro confirmation.EBI
Chonnam National University
9
Inhibition and structural reliability of prenylated flavones from the stem bark of Morus lhou on β-secretase (BACE-1).EBI
Gyeongsang National University
4
Structure-based virtual screening approach to the discovery of phosphoinositide 3-kinase alpha inhibitors.EBI
Sejong University
42
2-Arylbenzoxazoles as CETP inhibitors: raising HDL-C in cynoCETP transgenic mice.EBI
Merck Research Laboratories
14
Arylpiperazine-containing pyrimidine 4-carboxamide derivatives targeting serotonin 5-HT(2A), 5-HT(2C), and the serotonin transporter as a potential antidepressant.EBI
Green Cross
10
 
Evaluation of heterocyclic acid equivalents as tetrazole replacements in imidazopyridine-based nonpeptide angiotensin II receptor antagonistsEBI
TBA
22
 
Acidic phenols: a new class of potent nonpeptide angiotensin II receptor antagonistsEBI
TBA
21
 
Imidazo[4,5-b]pyridine-based AT1 / AT2 angiotensin II receptor antagonistsEBI
TBA
28
Discovery of thiophen-2-ylmethylene bis-dimedone derivatives as novel WRN inhibitors for treating cancers with microsatellite instability.EBI
Korea University
33
Structural Modification and Biological Evaluation of 2,8-Disubstituted Adenine and Its Nucleosides as A2A Adenosine Receptor Antagonists: Exploring the Roles of Ribose at Adenosine Receptors.EBI
Seoul National University
17
Design, synthesis, and biological evaluation of triazolopiperazine-based beta-amino amides as potent, orally active dipeptidyl peptidase IV (DPP-4) inhibitors.EBI
Merck Research Laboratories
37
Identification and Biological Evaluation of a Potent and Selective JAK1 Inhibitor for the Treatment of Pulmonary Fibrosis.EBI
Ewha Womans University
33
Triazolopiperazine-amides as dipeptidyl peptidase IV inhibitors: close analogs of JANUVIA (sitagliptin phosphate).EBI
Merck Research Laboratories
42
2-Amino-1,3,4-thiadiazoles as Glutaminyl Cyclases Inhibitors Increase Phagocytosis through Modification of CD47-SIRPα Checkpoint.EBI
Ewha Womans University
12
Drug-like Inhibitors of DC-SIGN Based on a Quinolone Scaffold.EBI
Max Planck Institute of Colloids and Interfaces
29
Potent 1,3,4-trisubstituted pyrrolidine CCR5 receptor antagonists: effects of fused heterocycles on antiviral activity and pharmacokinetic properties.EBI
Merck Research Laboratories
1
Discovery of a 2,4-diphenyl-5,6-dihydrobenzo(h)quinolin-8-amine derivative as a novel DNA intercalating topoisomerase IIα poison.EBI
Yeungnam University
18
Discovery of G Protein-Biased Ligands against 5-HTEBI
Korea Institute of Science and Technology
1
Optimization and Evaluation of Novel Antifungal Agents for the Treatment of Fungal Infection.EBI
Korea Institute of Science & Technology (Kist)
22
Discovery of G Protein-Biased Antagonists against 5-HTEBI
Korea Institute of Science and Technology
31
Design and Synthesis of TRAP1 Selective Inhibitors: H-Bonding with Asn171 Residue in TRAP1 Increases Paralog Selectivity.EBI
Ewha Womans University
9
Design, synthesis and biological evaluation of new bivalent quinazoline analogues as IAP antagonists.EBI
Chung-Ang University
2
The food-grade antimicrobial xanthorrhizol targets the enoyl-ACP reductase (FabI) in Escherichia coli.EBI
Yonsei University
19
Design, synthesis, and SAR of heterocycle-containing antagonists of the human CCR5 receptor for the treatment of HIV-1 infection.EBI
Merck Research Laboratories
16
Discovery of human CCR5 antagonists containing hydantoins for the treatment of HIV-1 infection.EBI
Merck Research Laboratories
10
Design, Synthesis, and Biological Evaluation of New Peripheral 5HTEBI
Gwangju Institute of Science and Technology
32
Discovery of 2-((4-resorcinolyl)-5-aryl-1,2,3-triazol-1-yl)acetates as potent Hsp90 inhibitors with selectivity over TRAP1.EBI
Daegu-Gyeongbuk Medical Innovation Foundation (Dgmif)
50
Potent, orally absorbed glucagon receptor antagonists.EBI
Merck Research Laboratories
1
Glechomanamides A-C, Germacrane Sesquiterpenoids with an Unusual ΔEBI
Seoul National University
12
Dieckol, a SARS-CoV 3CL(pro) inhibitor, isolated from the edible brown algae Ecklonia cava.EBI
Korea Research Institute of Bioscience and Biotechnology
16
Biflavonoids from Torreya nucifera displaying SARS-CoV 3CL(pro) inhibition.EBI
Korea Research Institute of Bioscience and Biotechnology
3
Synthesis of benzoxazole derivatives as interleukin-6 antagonists.EBI
Ewha Womans University
248
POLQ INHIBITORSBDB
AstraZeneca
81
Heterocyclic compounds as class II phosphoinositide 3-kinase inhibitorsBDB
Forschungsverbund Berlin
15
THERAPEUTIC MEDICINE FOR HEART DISEASE OR SKELETAL MUSCLE DISEASEBDB
Shionogi
26
PRMT5 INHIBITING COMPOUNDS AND USES THEREOFBDB
Antengene Discovery
6
Compositions and methods for the prevention and/or treatment of mitochondrial disease, including Friedreich's ataxiaBDB
Stealth Biotherapeutics
7
Phenyl-3,4-dihydroisoquinolin-2(1h)-yl-ethan-1-one derivatives as dopamine d1receptor positive allosteric modulatorsBDB
Eli Lilly
25
TRICYCLIC COMPOUNDSBDB
Recurium Ip Holdings
117
6-aryl-7-substituted-3-(1H-pyrazol-5-yl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines as inhibitors of the STAT3 pathway with anti-proliferative activityBDB
University of Pittsburgh
190
1 H-pyrazolo[4,3-B]pyridines as PDE1 inhibitorsBDB
H. Lundbeck
137
Imidazolonylquinolines and the use thereof as ATM kinase inhibitorsBDB
Merck Patent
105
1H-pyrazolo[3,4-b]pyridines and therapeutic uses thereofBDB
Samumed
28
Transformation of the Non-Selective Aminocyclohexanol-Based Hsp90 Inhibitor into a Grp94-Seletive Scaffold.BDB
The University of Kansas
18
Synthesis, Biological Evaluation, and Molecular Docking of 8-imino-2-oxo-2H,8H-pyrano[2,3-f]chromene Analogs: New Dual AChE Inhibitors as Potential Drugs for the Treatment of Alzheimer's Disease.BDB
Yogi Vemana University
53
4-substituted-cyclohexylamino-4-piperidinyl-acetamide antagonists of CCR2BDB
Janssen Pharmaceutica
11
In vitro binding characteristics of a new selective group II metabotropic glutamate receptor radioligand, [3H]LY354740, in rat brain.BDB
F. Hoffmann-La Roche
1
Human serotonin 5-HT7 receptor: cloning and pharmacological characterisation of two receptor variants.BDB
Organon
12
Design and campaign synthesis of piperidine- and thiazole-based histone deacetylase inhibitors.BDB
AstraZeneca